Crop Life Science Limited IPO: Issue Price, Listing Gain and Share Price Now
Crop Life Science Limited listed on 30-Aug-2023 at ₹53.15 against an issue price of ₹52 , a listing gain of +2.21%. It last traded at ₹82.65. This page is the record of that issue and what has happened to it since — reported figures only.
Crop Life Science Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹52 |
| Listing price (listing-day close) | ₹53.15 |
| Listing gain | +2.21% |
| Price now | ₹82.65 |
| Change from issue price | +58.94% |
| Change from listing-day close | +55.50% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Crop Life Science Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹52 |
| Issue size | ₹25.38 Cr |
| Fresh issue | ₹25.38 Cr |
| Issue opened | 18-Aug-2023 |
| Issue closed | 22-Aug-2023 |
| Listed on | 30-Aug-2023 |
| Exchange | NSE SME |
| Segment | SME |
| Lead managers | Interactive Financial (left lead) |
How the Crop Life Science Limited IPO was subscribed
| Category | Subscription |
|---|---|
| NII | 1.56x |
| Retail | 7.15x |
| Total | 4.36x |
Crop Life Science Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹142 Cr |
| Trailing P/E | 21.50x |
| Return on capital employed | 10.8% |
| Return on equity | 8.2% |
| 52-week high | ₹83.2 |
| 52-week low | ₹39 |
| Sector | Pesticides & Agrochemicals |
Fundamentals are as of the desk's last harvest and move with the market.
- Crop Life Science Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.